161 related articles for article (PubMed ID: 10213177)
1. Sphingolipid metabolism during human platelet activation.
Simon CG; Gear AR
Thromb Res; 1999 Apr; 94(1):13-23. PubMed ID: 10213177
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate breakdown in platelets.
Yatomi Y; Yamamura S; Hisano N; Nakahara K; Igarashi Y; Ozaki Y
J Biochem; 2004 Oct; 136(4):495-502. PubMed ID: 15625319
[TBL] [Abstract][Full Text] [Related]
3. Distribution and dynamic changes of sphingolipids in blood in response to platelet activation.
Dahm F; Nocito A; Bielawska A; Lang KS; Georgiev P; Asmis LM; Bielawski J; Madon J; Hannun YA; Clavien PA
J Thromb Haemost; 2006 Dec; 4(12):2704-9. PubMed ID: 17010150
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelinase activity in human platelets.
Simon CG; Chatterjee S; Gear AR
Thromb Res; 1998 May; 90(4):155-61. PubMed ID: 9692614
[TBL] [Abstract][Full Text] [Related]
5. Quantification of sphingosine derivatives in human platelets: inducible formation of free sphingosine.
Hisano N; Yatomi Y; Fujino MA; Igarashi Y; Kume S; Ozaki Y
J Biochem; 1998 Feb; 123(2):263-8. PubMed ID: 9538201
[TBL] [Abstract][Full Text] [Related]
6. The effect of thrombin on the organization of human platelet membrane glycosphingolipids. The sphingosine composition of platelet glycolipids and ceramides.
Wang CT; Schick PK
J Biol Chem; 1981 Jan; 256(2):752-6. PubMed ID: 7451473
[TBL] [Abstract][Full Text] [Related]
7. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
8. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids in mammalian cell signalling.
Ohanian J; Ohanian V
Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets.
Yatomi Y; Ruan F; Hakomori S; Igarashi Y
Blood; 1995 Jul; 86(1):193-202. PubMed ID: 7795224
[TBL] [Abstract][Full Text] [Related]
11. Different effects of cell-permeable ceramide analogs on platelet activation.
Hashizume T; Kageura T; Sato T
Biochem Mol Biol Int; 1998 Mar; 44(3):489-96. PubMed ID: 9556209
[TBL] [Abstract][Full Text] [Related]
12. Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat.
McVey MJ; Weidenfeld S; Maishan M; Spring C; Kim M; Tabuchi A; Srbely V; Takabe-French A; Simmons S; Arenz C; Semple JW; Kuebler WM
Blood; 2021 Feb; 137(5):690-701. PubMed ID: 33232973
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelin metabolites inhibit sphingomyelin synthase and CTP:phosphocholine cytidylyltransferase.
Vivekananda J; Smith D; King RJ
Am J Physiol Lung Cell Mol Physiol; 2001 Jul; 281(1):L98-L107. PubMed ID: 11404252
[TBL] [Abstract][Full Text] [Related]
14. The differential regulation of cyclic AMP by sphingomyelin-derived lipids and the modulation of sphingolipid-stimulated extracellular signal regulated kinase-2 in airway smooth muscle.
Pyne S; Pyne NJ
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):917-23. PubMed ID: 8645177
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
16. Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle.
Pyne S; Chapman J; Steele L; Pyne NJ
Eur J Biochem; 1996 May; 237(3):819-26. PubMed ID: 8647130
[TBL] [Abstract][Full Text] [Related]
17. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipid metabolism and cell growth regulation.
Spiegel S; Merrill AH
FASEB J; 1996 Oct; 10(12):1388-97. PubMed ID: 8903509
[TBL] [Abstract][Full Text] [Related]
19. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
20. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
